IP Library Patent Application 12491199
Patent Application
App. No. 12/491,199

Methods and Medicaments for Administration of Ibuprofen

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/491,199
Abstract

A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided, in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine is administered three times per day.

Claims (7)

1 - 11 . (canceled)

12 . A method comprising:

administering to a patient a first dose of an oral dosage form comprising famotidine and a therapeutically effective dose of a non-steroidal anti-inflammatory drug (NSAID)

administering a second dose of the oral dosage form;

administering a third dose of the oral dosage form,

wherein the first dose, the second dose, and the third dose are administered within a 24 hour dosing cycle, wherein the total daily dose of famotidine administered is 75 mg to 85 mg.

13 . An oral unit dosage form comprising 25 mg to 28.3 mg famotidine and a therapeutically effective amount of a non-steroidal anti-inflammatory drug (NSAID).

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS IRELAND DAC (SUCCESSOR IN INTEREST TO HORIZON PHARMA SERVICES LIMITED); HORIZON THERAPEUTICS IRELAND DAC (FKA HORIZON PHARMA IRELAND LIMITED); HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.); HZNP LIMITED
Reel/Frame 065153/0953 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2018
From: HORIZON PHARMA USA, INC.
To: HORIZON MEDICINES LLC
Reel/Frame 046470/0808 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT EXECUTION DATE PREVIOUSLY RECORDED AT REEL: 035591 FRAME: 0028. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Aug 6, 2015
From: HORIZON PHARMA USA, INC.
To: CITIBANK, N.A.
Reel/Frame 036303/0708 →
SECURITY INTEREST Recorded May 7, 2015
From: HORIZON PHARMA USA, INC.
To: CITIBANK, N.A.
Reel/Frame 035591/0028 →
RELEASE OF SECURITY INTEREST Recorded Dec 3, 2013
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: HORIZON PHARMA USA, INC.
Reel/Frame 031709/0458 →
PATENT SECURITY AGREEMENT Recorded Feb 29, 2012
From: HORIZON PHARMA USA, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC
Reel/Frame 027784/0378 →
CHANGE OF NAME Recorded Aug 5, 2010
From: HORIZON THERAPEUTICS, INC.
To: HORIZON PHARMA USA, INC.
Reel/Frame 024798/0016 →